BPIFA1 and asthma: Indeed, we have recently shown that a peptidomimetic of SPLUNC1’s α6 region ameliorates inflammation in a house dust mite‐sensitized mouse model of asthma (Wrennall et al., 2022), suggesting that SPLUNC1 replacement therapy may be a novel approach to treat pulmonary inflammation.